Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients

Life Sciences
Annique SchinsAdriaan Honig


Depression is an independent risk factor for post myocardial infarction (MI) mortality. Abnormalities in platelet function have been proposed as one of the mechanisms involved in increased cardiovascular risk among patients with depression post-MI. Depression in somatically healthy patients has been associated with increased platelet activation. Some but not all studies showed changes in blood serotonin level. Increased platelet activation and blood serotonin level have been associated with increased risk of cardiac events in patients with MI. The goal of this study was to investigate whether 1) depressed post-MI patients have higher markers of platelet activation as measured by plasma levels of beta-thromboglobulin (betaTG), platelet factor 4 (PF4) and soluble CD40 ligand (sCD40L) and higher serotonin (5-HT) levels than non-depressed post-MI patients and 2) treatment with the antidepressant mirtazapine decreases platelet activation. In this study, 25 depressed post-MI patients were asked for blood collection before start as well as after 8 weeks treatment with mirtazapine or placebo. The control group (n=22) consisted of non-depressed post-MI patients, matched for age, gender and time elapsed since MI. Plasma levels of betaTG,...Continue Reading


Dec 1, 1992·Psychiatry Research·H D'haenenL Kaufman
Jan 1, 1991·Journal of Cardiovascular Pharmacology·P M Vanhoutte
Aug 1, 1991·Psychiatry Research·D Mück-SelerZ Deanović
May 1, 1990·Journal of the American College of Cardiology·T P GavaghanC N Chesterman
Jun 1, 1985·Circulation·S P LevineJ N George
Oct 1, 1984·Psychiatry Research·K H Le Quan-BuiP Meyer
Jun 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H al MardiniC O Record
Oct 1, 1994·Circulation·R PakalaC R Benedict
Nov 1, 1993·Psychosomatic Medicine·S B MalkoffS B Manuck
Oct 1, 1996·The American Journal of Psychiatry·D L MusselmanC B Nemeroff
Aug 3, 1999·Circulation·K VikenesJ E Nordrehaug
Jun 1, 2000·The American Journal of Psychiatry·J H MarkovitzL C Tolbert
Sep 15, 2000·Archives of General Psychiatry·D L MusselmanC B Nemeroff
Feb 13, 2001·Journal of Psychiatric Research·J E PiletzA Halaris
Sep 8, 2001·The American Journal of Cardiology·D E BushJ A Fauerbach
Nov 7, 2001·Circulation·U SchönbeckP M Ridker
Feb 14, 2002·International Journal of Psychiatry in Medicine·J J StrikH M van Praag
Jul 12, 2002·American Journal of Hematology·David GurneyAndrew D Blann
Aug 21, 2002·Circulation·Patrick AndréDavid R Phillips

❮ Previous
Next ❯


Nov 27, 2008·JAMA : the Journal of the American Medical Association·Mary A WhooleyWarren S Browner
Jun 29, 2006·JAMA : the Journal of the American Medical Association·Mary A Whooley
Mar 20, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H KälvegrenA Richter
Apr 6, 2011·Cardiology in Review·Christopher M Celano, Jeff C Huffman
Mar 5, 2011·The Journal of Cardiovascular Nursing·Jennifer E Sanner, Lorraine Frazier
Mar 30, 2013·Annual Review of Clinical Psychology·Mary A Whooley, Jonathan M Wong
Sep 15, 2009·Psychiatry Research·Sharareh HamidifardBahram Pourghassem Gargari
Dec 31, 2008·Pharmacotherapy·Kristin Watson, Kelly M Summers
May 9, 2013·Cardiovascular Psychiatry and Neurology·Jeff C HuffmanJames L Januzzi
Apr 30, 2013·Progress in Cardiovascular Diseases·Larkin Elderon, Mary A Whooley
Mar 25, 2009·American Journal of Hypertension·Anne B Wallis, Audrey F Saftlas
Feb 11, 2014·Therapeutic Advances in Cardiovascular Disease·Lauren WrightMeir Steiner
Sep 9, 2011·The Cochrane Database of Systematic Reviews·Harald BaumeisterJürgen Bengel
Nov 7, 2012·Journal of the American Heart Association·S Marlene GrenonBeth E Cohen
Dec 13, 2006·Harvard Review of Psychiatry·Jeff C HuffmanGregory L Fricchione
Jul 14, 2009·Journal of Clinical Psychopharmacology·Ahmet Ataoglu, Fatih Canan
Mar 12, 2019·Psychosomatic Medicine·Marlene S WilliamsDhananjay Vaidya
Jul 2, 2008·Expert Review of Neurotherapeutics·Astrid M G Kuyper, Adriaan Honig
Mar 15, 2019·CNS & Neurological Disorders Drug Targets·Maria PodsiedlikJoanna Sikora
Sep 22, 2009·Expert Review of Cardiovascular Therapy·Giuseppe MaranoMarianna Mazza
Nov 26, 2020·International Journal of Molecular Sciences·Benedetta IzziAlessandro Gialluisi
Feb 2, 2021·Biological & Pharmaceutical Bulletin·Yohei KawanoTakao Aoyama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.